Navigation Links
Cathine leads to mental health disorder,,

Cathine a chemical found in a herb called Khat has been linked to an increase in suicide among people who use it. Khat is an African shrub whose leaves remain potent only for a few days after picking.//It has several side effects which include appetite suppression, insomnia and anxiety.

Its leaves are packed with the chemical cathine and have a similar effect to amphetamines when chewed. They say the drug, which is banned in the US and most other European countries, is causing massive mental health problems among their young men.


'"/>




Page: 1

Related medicine news :

1. Drinking arsenic water leads to cancer
2. Coronary stent leads to complications
3. Starving leads to obesity
4. Drug abuse leads to long standing changes in the brain
5. Deprived sleep leads to ageing
6. Tobacco chewing leads to dental caries
7. Tongue piercing leads to bacterial infection
8. Space research leads to needle-free blood tests
9. Canada stunned as mad cow discovery leads to beef ban
10. Doctor Pleads Not Guilty
11. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cathine leads mental health disorder

(Date:10/13/2008)...hkosh is one of six sites included in national stu...t survival rates, OSHKOSH, Wis., Oct. 13 /PRNewsw...//www.advancedcirculatory.com ) announced today th...unding from the National Institutes,of Health (NIH...combination,on those who experience cardiac arrest...
(Date:10/13/2008)...ine Exercises to Build and Maintain a Healthy Spin...fort to educate people,about spine health, Texas B...lease of these nine easy exercises coincides with ...ional Spine Health Day was established to bring at... most effective means of reducing the,prevalence a...
(Date:10/13/2008)... CoreValve ( www.corevalve.com ) annou...f its ReValving System for percutaneous aortic val...ortic stenosis continues to enroll patients at an ...ow been treated worldwide at nearly 100 centers in... Calif. (Business Wire EON) October 13, 2008 -- D...
(Date:10/13/2008)... is a significant problem in daily life, survey sh...re/ -- Approximately,three-quarters of people livi... problem in daily life, according to a National Ps...he survey of 426 individuals with psoriasis and ps... influences their daily lives, shapes their,feelin...
Breaking Medicine News(10 mins):Health News:Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques 2Health News:Texas Back Institute Announces 'Nine for Your Spine' for National Spine Health Day - October 16 2Health News:Texas Back Institute Announces 'Nine for Your Spine' for National Spine Health Day - October 16 3Health News: CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008 2Health News:National Psoriasis Foundation Releases 2008 Study Results 2
...ories Limited has recently launched its approved g...elease tablets in the US, according to a press rel...anufacture and market Clarithromycin tablets—250 m...ycin tablets are indicated for the treatment of mi...
...ed by University of California-San Francisco has p... ephedra and guarana changes the cardiovascular sy...sure. It also has negative influence on glucose an...arheaded by Dr. Christine A. Haller and colleagues...
...e identified the single mutation of the gene invol...yndrome or primary erythromelalgia. Investigators ...r research findings that the single mutation of th...sponsible for people to suffer from the chronic co...
... shown that smoking during pregnancy is associated...an reverse this. Smoking during pregnancy is assoc...resent study had evaluated the relation between ma... monoxide (CO) concentrations (EACO) on the growth...
Other Medicine News:
(Date:10/13/2008)...ion of Genomic DNA from Multiple Cancer Population...tudies, ANN ARBOR, Mich., Oct. 13 /-...nt with SAIC-Frederick to amplify DNA samples for ...s was selected to amplify and standardize total ge... cancer patients. The Rubicon,GenomePlex(TM) Whole...
(Date:10/12/2008)... siRNAs Examined Alone and in Combination with Che...- Quark Pharmaceuticals, Inc., a,development-stage... novel,RNA interference (RNAi)-based therapeutics,...published results on efficacy of siRNA targeting,i...lung cancer (NSCLC) in,the edition dated October 1...
(Date:10/12/2008)...K, Mass. and WASHINGTON, Oct. 12 /PRNewswire-First... ) today announced results from an analysis,of nea...egistries, which,are designed to confirm the perfo...ting Coronary Stent System in real-world practice....AXUS Stent reduced clinical,restenosis in patients...
(Date:10/10/2008)...Z CREEK, Mich., Oct. 10 /- Diplomat S...cience has selected Diplomat,Specialty Pharmacy to...rge,scale, national Therapy Optimization Study for...wo year TOP MS study, is to examine the benefits o...on compliance, adherence and,patient outcomes. Tar...
Breaking Medicine Technology:Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Rice scientists make breakthrough in single molecule sensing 2138 1Rice scientists make breakthrough in single molecule sensing 2138 2Genesee 26 Wyoming Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11155 1Genesee 26 Wyoming Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11155 2Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 1330 1Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 1330 2Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 1330 3Charles River Laboratories International Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11147 1Charles River Laboratories International Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11147 2
...E)--May 24, 2007 - Inovio Biomedical,Corporation (... DNA,vaccines for cancers and infectious diseases ...zed cancers, announced today,that interim clinical...otherapy delivered by Inovio,s electroporation tec...xpression, and resulted in,significant objective t...
...Activity Demonstrated Among Patients with,Active D...swire/ --,ChemoCentryx, Inc., a clinical-stage bio...eloping and commercializing,orally-administered th...nted data today from the company,s Phase 2 clinica...e anti-inflammatory agent,that targets the chemoki...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 2Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 3Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 4Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 5ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 2ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 3ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 4ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 5
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: